Covered recipient · General Payments record
MARTIN ZISBLATT
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2023–2024
$696.95
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $498.72 | 24 |
| Education | $94.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $206.57 | 11 |
| Amgen Inc. | $146.69 | 5 |
| Janssen Biotech, Inc. | $94.99 | 1 |
| Regeneron Healthcare Solutions, Inc. | $38.95 | 2 |
| Arcutis Biotherapeutics, Inc. | $29.94 | 2 |
| Incyte Corporation | $28.56 | 2 |
| LEO Pharma Inc. | $26.54 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.27 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399539 | CMS |
| ABBVIE INC. | $28.26 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399541 | CMS |
| ABBVIE INC. | $24.26 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399543 | CMS |
| ABBVIE INC. | $27.23 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399545 | CMS |
| ABBVIE INC. | $32.23 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399547 | CMS |
| ABBVIE INC. | $20.61 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399549 | CMS |
| ABBVIE INC. | $6.85 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399551 | CMS |
| ABBVIE INC. | $8.92 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399553 | CMS |
| ABBVIE INC. | $18.20 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399555 | CMS |
| ABBVIE INC. | $7.97 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399557 | CMS |
| ABBVIE INC. | $6.77 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399559 | CMS |
| Amgen Inc. | $29.49 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117422974 | CMS |
| Amgen Inc. | $27.84 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117422976 | CMS |
| Amgen Inc. | $30.65 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117422978 | CMS |
| Amgen Inc. | $29.66 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117422980 | CMS |
| Amgen Inc. | $29.05 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117422982 | CMS |
| Arcutis Biotherapeutics, Inc. | $14.73 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121062612 | CMS |
| Arcutis Biotherapeutics, Inc. | $15.21 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121062614 | CMS |
| Incyte Corporation | $15.15 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141249052 | CMS |
| Incyte Corporation | $13.41 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141246706 | CMS |
| Janssen Biotech, Inc. | $94.99 | 05/27/2024 | Education | Undisputed | 01/23/2026 | 1078479300 | CMS |
| LEO Pharma Inc. | $26.54 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152657007 | CMS |
| Novartis Pharmaceuticals Corporation | $21.47 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087441646 | CMS |
| Regeneron Healthcare Solutions, Inc. | $17.21 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114262476 | CMS |
| Regeneron Healthcare Solutions, Inc. | $21.74 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114262478 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.